MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | - | - | ₹1.45 Cr | ₹1.45 Cr | ₹20 Cr |
What is the latest Contingent Liabilities ratio of MARKSANS PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | ₹1.45 Cr |
| Mar2022 | ₹1.45 Cr |
| Mar2021 | ₹20 Cr |
How is Contingent Liabilities of MARKSANS PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | -100.00 | |
| Mar2023 | ₹1.45 Cr | 0.00 | |
| Mar2022 | ₹1.45 Cr | -92.68 | |
| Mar2021 | ₹20 Cr | - | |
Compare Contingent Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹10,559.6 Cr | -2.3% | 18.7% | -8.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,933.0 Cr | -0.7% | -3.6% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,833.0 Cr | 1.1% | -1.2% | -0.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,549.0 Cr | 1.6% | 1.4% | 36.7% | Stock Analytics | |
| CIPLA | ₹113,155.0 Cr | 0.7% | 2.6% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,652.0 Cr | -0.9% | -2.5% | 1.2% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -2.3% |
18.7% |
-8.5% |
| SENSEX | -0.7% |
-3.6% |
-9.1% |
You may also like the below Video Courses